Patent details

Title (priority date) Use of protease nexin 1 inhibitors to reduce metastasis (6.12.2007)
Reference: 52358
Inventors: Fayard & Monard
Description: This application relates to the use of inhibitors of Pin-1 (protease nexin 1 or SERPIN2) for reducing metastasis. Treament of mice having a primary tumour in their mamary fat pads with such inhibitors resulted in a drastic reduction of lung metastases.
Applications: Cancer therapy
Status: Pending EP & US
Opportunity: Exclusive and non exclusive license
Contact: Dr. Nicolas Favre, tel: +41 61 6978382, e-mail:
PCT File: WO2009/071660
About this site2018 © FMI Basel Switzerland